Venture
Candid Therapeutics, Inc.
Latest Form D 2024-09-13- CIK 2035778
- State CA
- Other Health Care
- 1 Form D offering since 2024-09-13
- Total sold
- $206M
- across its one offering
- Rounds
- 1
- Form D offerings since 2024-09-13
- Latest round
- $206M
- 2024-09-13 · 021-524038
- Investors
- 33
- on the latest round
Connected
named in its Form D filingsOfferings · since 2024-09-131 Form D offeringExemptions506(b)People · Item 3Kenneth Song, M.D. + 6 moreInvestors · dashboard2 inferred investors
Candid Therapeutics, Inc.CIK 2035778
Round timeline
amount sold · by first filed2024-09-13 · $206M
- 2024-09-13$206M021-524038
Hover a dot or row, or tab through the dots · bars scaled to the largest round ($206M)
Form D offerings
One line per offering, amendments folded in, newest first
| File | First filed | Latest | Sought | Sold | Investors | Exemptions |
|---|---|---|---|---|---|---|
| 021-524038 | First filed2024-09-13 | Latest2024-09-13 | Sought$206M | Sold$206M | Investors33 | Exemptions506(b) |
Who backs Candid Therapeutics, Inc. — 2 inferred investors — and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2024-09-13
| Name | Relationship |
|---|---|
| Kenneth Song, M.D. | RelationshipExecutive Officer, Director |
| Aaron Royston, M.D. | RelationshipDirector |
| Michael Rome, M.D. | RelationshipDirector |
| Jeffrey Tong, Ph.D. | RelationshipDirector |
| Arvind Kush | RelationshipExecutive Officer |
| Timothy Lu, M.D. | RelationshipExecutive Officer |
| Bernie Huyghe, Ph.D. | RelationshipExecutive Officer |
Facts
As its latest Form D states them
- Industry
- Other Health Care
- State
- California (CA)
- Exemptions
- Rule 506(b)
- First filed
- 2024-09-13
- Latest filing
- 2024-09-13
Who backs Candid Therapeutics, Inc.
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
- Inferred investors — the funds and firms behind it, from co-filings and shared people
- Every Form D and amendment as filed, with what each one stated
- Its rounds in sequence: the gap between them and whether they grew
- Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)
See plansExternal link: SEC Filings ↗